Iron deprivation induces EFG1-mediated hyphal development in Candida albicans without affecting biofilm formation.

In this study, we investigated the role of cellular iron status in hyphae and biofilm formation in Candida albicans. Iron deprivation by a chelator, bathophenanthrolene disulfonic acid, promoted hyphal development even in nonhyphal-inducing media without affecting growth of C. albicans cells. Iron-acquisition defective mutants, Deltaftr1 and Deltaccc2, also showed hyphal formation, which was prevented by iron supplementation. Notably, most of the tested morphological mutants Deltacph1, Deltaefh1 and Deltatpk1 continued to form hyphae under iron-deprived conditions, except the Deltaefg1 null mutant, which showed a complete block in hyphae formation. The role of EFG1 in filamentation under iron-deprived conditions was further confirmed by Northern analysis, which showed a considerable upregulation of the EFG1 transcript. Of notable importance, all the morphological mutants including Deltaefg1 mutant possessed enhanced membrane fluidity under iron-deprived conditions; however, this did not appear to contribute to hyphal development. Interestingly, iron deprivation did not affect the ability of C. albicans to form biofilms on the catheter surface and led to no gross defects in azole resistance phenotype of these biofilms of C. albicans cells. Our study, for the first time, establishes a link between cellular iron, Efg1p and hyphal development of C. albicans cells that is independent of biofilm formation.

[1]  R. Prasad,et al.  Dosage-dependent functions of fatty acid desaturase Ole1p in growth and morphogenesis of Candida albicans. , 2004, Microbiology.

[2]  R. Prasad,et al.  Alterations in fatty acyl composition can selectively affect amino acid transport in Saccharomyces cerevisiae. , 1987, Biochemistry international.

[3]  H. Rogers,et al.  Natural resistance, iron and infection: a challenge for clinical medicine. , 2006, Journal of medical microbiology.

[4]  T. C. White,et al.  Resistance Mechanisms in Clinical Isolates of Candida albicans , 2002, Antimicrobial Agents and Chemotherapy.

[5]  A. Brown,et al.  Regulatory networks controlling Candida albicans morphogenesis. , 1999, Trends in microbiology.

[6]  T. Emery.  Iron deprivation as a biological defence mechanism , 1980, Nature.

[7]  R. Prasad,et al.  Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.

[8]  M. Ghannoum,et al.  Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism , 2003, Journal of Clinical Microbiology.

[9]  Gordon Ramage,et al.  The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. , 2002, FEMS microbiology letters.

[10]  D. Roberts,et al.  Hemoglobin is an effective inducer of hyphal differentiation in Candida albicans. , 2007, Medical mycology.

[11]  D. Irwin,et al.  Isogenic strain construction and gene mapping in Candida albicans. , 1993, Genetics.

[12]  Gordon Ramage,et al.  Candida biofilms on implanted biomaterials: a clinically significant problem. , 2006, FEMS yeast research.

[13]  Mahmoud A. Ghannoum,et al.  Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.

[14]  J. Mekalanos.  Environmental signals controlling expression of virulence determinants in bacteria , 1992, Journal of bacteriology.

[15]  S. Sweet,et al.  Effect of iron deprivation on surface composition and virulence determinants of Candida albicans. , 1991, Journal of general microbiology.

[16]  M. Ghannoum,et al.  Temporal analysis of Candida albicans gene expression during biofilm development. , 2007, Microbiology.

[17]  E. Weinberg.  The Role of Iron In Protozoan and Fungal Infectious Diseases , 1999, The Journal of eukaryotic microbiology.

[18]  D. Kelly,et al.  Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation , 1997, FEBS letters.

[19]  C. Vágvölgyi,et al.  Iron gathering of opportunistic pathogenic fungi. A mini review. , 2005, Acta microbiologica et immunologica Hungarica.

[20]  M. Ghannoum,et al.  Endothelial Cell Injury Caused by Candida albicans Is Dependent on Iron , 1998, Infection and Immunity.

[21]  J. Becker,et al.  Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene , 1994, Antimicrobial Agents and Chemotherapy.

[22]  A. Dancis,et al.  Reduction of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) is dependent on CaFRE10 ferric reductase for Candida albicans grown in unbuffered media. , 2006, Microbiology.

[23]  E. Greenberg,et al.  Iron and Pseudomonas aeruginosa biofilm formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Jradi,et al.  Quantitation of Ergosterol Content: Novel Method for Determination of Fluconazole Susceptibility of Candida albicans , 1999, Journal of Clinical Microbiology.

[25]  J. Morschhäuser,et al.  Molecular aspects of fluconazole resistance development in Candida albicans , 1999, Mycoses.

[26]  R. Cannon,et al.  Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance , 1996, Antimicrobial agents and chemotherapy.

[27]  M. Bard,et al.  Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae , 1998, Yeast.

[28]  J. Ernst,et al.  Dimorphism in human pathogenic and apathogenic yeasts , 2000 .

[29]  J. Ernst,et al.  Chlamydospore Formation in Candida albicans Requires the Efg1p Morphogenetic Regulator , 1999, Infection and Immunity.

[30]  V. Gupta,et al.  Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation , 1998, Current Genetics.

[31]  D. Kornitzer,et al.  Deletion of the copper transporter CaCCC2 reveals two distinct pathways for iron acquisition in Candida albicans , 2002, Molecular microbiology.

[32]  J. Bennett,et al.  Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion , 1996, Antimicrobial agents and chemotherapy.

[33]  N. Tsuji,et al.  Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect , 2002, Antimicrobial Agents and Chemotherapy.

[34]  R. Prasad,et al.  Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid Composition , 2002, Antimicrobial Agents and Chemotherapy.

[35]  D. Radisky,et al.  Regulation of Transition Metal Transport across the Yeast Plasma Membrane* , 1999, The Journal of Biological Chemistry.

[36]  F. Chapeland-leclerc,et al.  Contributions of the Response Regulators Ssk1p and Skn7p in the Pseudohyphal Development, Stress Adaptation, and Drug Sensitivity of the Opportunistic Yeast Candida lusitaniae , 2008, Eukaryotic Cell.

[37]  S. Kohno,et al.  [Azole resistance in Candida spp]. , 2003, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[38]  D. Kelly,et al.  Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains , 1998, Antimicrobial Agents and Chemotherapy.

[39]  T. C. White,et al.  Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.

[40]  R. Prasad,et al.  Relationship between ethanol tolerance and fatty acyl composition of Saccharomyces cerevisiae , 1989, Applied Microbiology and Biotechnology.

[41]  M. Schaller,et al.  The Siderophore Iron Transporter of Candida albicans (Sit1p/Arn1p) Mediates Uptake of Ferrichrome-Type Siderophores and Is Required for Epithelial Invasion , 2002, Infection and Immunity.

[42]  M. Casanova,et al.  Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA , 1994, Archives of Microbiology.

[43]  Brian C. Baldwin,et al.  The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity* , 1997, The Journal of Biological Chemistry.

[44]  G. Fink,et al.  Nonfilamentous C. albicans Mutants Are Avirulent , 1997, Cell.

[45]  Thomas Doedt,et al.  Transcriptional response of Candida albicans to hypoxia: linkage of oxygen sensing and Efg1p-regulatory networks. , 2006, Journal of molecular biology.

[46]  M. Franklin,et al.  Strain-specific proteome responses of Pseudomonas aeruginosa to biofilm-associated growth and to calcium. , 2007, Microbiology.

[47]  Alistair J. P. Brown,et al.  APSES proteins regulate morphogenesis and metabolism in Candida albicans. , 2004, Molecular biology of the cell.

[48]  R. Prasad,et al.  In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry , 2002, Antimicrobial Agents and Chemotherapy.

[49]  R. Curi,et al.  Effects of short chain fatty acids on effector mechanisms of neutrophils , 2009, Cell biochemistry and function.

[50]  M. Laverdière,et al.  Inactivation of Sterol Δ5,6-Desaturase Attenuates Virulence in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[51]  Rajendra Prasad,et al.  Unexpected Link between Iron and Drug Resistance of Candida spp.: Iron Depletion Enhances Membrane Fluidity and Drug Diffusion, Leading to Drug-Susceptible Cells , 2006, Antimicrobial Agents and Chemotherapy.

[52]  E. Weinberg,et al.  Iron loading and disease surveillance. , 1999, Emerging infectious diseases.

[53]  John Karijolich,et al.  Metal-dependent repression of siderophore and biofilm formation in Actinomyces naeslundii. , 2007, FEMS microbiology letters.

[54]  N. Ramanan,et al.  A high-affinity iron permease essential for Candida albicans virulence. , 2000, Science.

[55]  J. Ernst,et al.  Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi , 1997, The EMBO journal.

[56]  A. Johnson,et al.  TUP1, CPH1 and EFG1 make independent contributions to filamentation in candida albicans. , 2000, Genetics.

[57]  E. Weinberg.  Iron withholding: a defense against infection and neoplasia. , 1984, Physiological reviews.

[58]  J. Ernst,et al.  Control of White-Opaque Phenotypic Switching inCandida albicans by the Efg1p Morphogenetic Regulator , 1999, Infection and Immunity.

[59]  Y. Ching,et al.  Efg1 Involved in Drug Resistance by Regulating the Expression of ERG3 in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[60]  Hening Lin,et al.  How pathogenic bacteria evade mammalian sabotage in the battle for iron , 2006, Nature chemical biology.

[61]  R. Vishwakarma,et al.  Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[62]  E. Weinberg,et al.  Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches. , 1995, Blood reviews.

[63]  M. Ghannoum,et al.  Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro , 2001, Journal of dental research.

[64]  I. Paulsen,et al.  Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.

[65]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[66]  M. Hronek,et al.  The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls , 2005, Mycoses.

[67]  J. Ernst,et al.  Distinct and redundant roles of the two protein kinase A isoforms Tpk1p and Tpk2p in morphogenesis and growth of Candida albicans , 2001, Molecular microbiology.

[68]  J. Ernst.  Transcription factors in Candida albicans - environmental control of morphogenesis. , 2000, Microbiology.

[69]  Z. Cabantchik,et al.  Iron Acquired from Transferrin by K562 Cells Is Delivered into a Cytoplasmic Pool of Chelatable Iron(II) (*) , 1995, The Journal of Biological Chemistry.

[70]  G. Baillie,et al.  Role of dimorphism in the development of Candida albicans biofilms. , 1999, Journal of medical microbiology.

[71]  M. Ghannoum,et al.  Candida biofilm: a well-designed protected environment. , 2005, Medical mycology.

[72]  Marcelo D. Vinces,et al.  Contributions of hyphae and hypha‐co‐regulated genes to Candida albicans virulence , 2005, Cellular microbiology.

[73]  D. Sanglard,et al.  Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.

[74]  George Newport,et al.  Regulatory networks affected by iron availability in Candida albicans , 2004, Molecular microbiology.

[75]  P. Milgram,et al.  A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. , 1996, Analytical biochemistry.

[76]  B. Wickes,et al.  Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA) , 2007, Mycopathologia.